Permanent Capital Management’s AbbVie ABBV Stock Holding History

Permanent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$911K	Hold	3,622	–	–	0.12%	58
2026 Q1	$772K	Buy	3,622 +71	+2%	+$15.7K	0.12%	60
2025 Q4	$811K	Buy	3,551 +442	+14%	+$101K	0.16%	63
2025 Q3	$720K	Buy	+3,109	New	+$633K	0.13%	69
2025 Q1	$651K	Buy	3,109 +1,816	+140%	+$353K	0.19%	27
2024 Q4	$230K	Buy	+1,293	New	+$238K	0.07%	60
2024 Q2	$577K	Buy	+3,109	New	+$515K	0.12%	76

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Permanent Capital Management's ABBV Position: Q2 2026 in Review

Permanent Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,622 shares worth $911K. The position accounts for 0.12% of the portfolio, ranked #58.

Permanent Capital Management first reported a position in ABBV in Q2 2024 and has held it in 7 quarters since. 4,231 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Permanent Capital Management held 3,622 shares of AbbVie worth $911K as of Q2 2026.
Permanent Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.12% of Permanent Capital Management's portfolio in Q2 2026, its #58 holding.
Permanent Capital Management first reported a position in AbbVie in Q2 2024 and has held it in 7 quarters since.
4,231 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Permanent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.